During the past decade, Stanford Sleep Medicine Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on
average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
2013-03-12
2018-10-03
Completed
872
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Stanford Sleep Medicine Center" #1 sponsor was "Jazz Pharmaceuticals" with 4 trials, followed by "Stanford University" with 4 trials
sponsored, "XenoPort, Inc." with 3 trials sponsored, "Avadel" with 2 trials sponsored and "Harmony Biosciences, LLC"
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford Sleep Medicine Center"
#1 collaborator was "Seven Dreamers Laboratories" with 1 trials as a collaborator and "Stanford University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Stanford Sleep Medicine Center
According to Clinical.Site data, the most researched conditions in "Stanford Sleep Medicine Center" are
"Narcolepsy" (7 trials), "Obstructive Sleep Apnea" (5 trials), "Excessive Daytime Sleepiness" (3 trials), "Idiopathic Hypersomnia" (3 trials) and "RLS" (3 trials). Many other conditions were trialed in "Stanford Sleep Medicine Center" in a lesser frequency.
Clinical Trials Intervention Types at Stanford Sleep Medicine Center
Most popular intervention types in "Stanford Sleep Medicine Center" are "Drug" (16 trials), "Device" (7 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "FT218" (2 trials), "HORIZANT 300 mg" (2 trials), "HORIZANT 600 mg" (2 trials) and "Xyrem" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Stanford Sleep Medicine Center
The vast majority of trials in "Stanford Sleep Medicine Center" are
25 trials for "All" genders.
Clinical Trials Status at Stanford Sleep Medicine Center
Currently, there are NaN active trials in "Stanford Sleep Medicine Center".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 18 completed trials in Stanford Sleep Medicine Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stanford Sleep Medicine Center, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 7 trials that are defined as “Not Applicable".